Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France
Negative perceptions of hepatitis B vaccination among attendees of an urban free testing center for sexually transmitted infections in France
复制标题
DOI：
10.1080/21645515.2016.1264549
复制
发表时间：
2017-01-01
影响因子：
4.8
通讯作者：
Epaulard, Olivier
中科院分区：
文献类型：
--
作者：
Moyroud, Lauranne;Hustache, Sarah;Epaulard, Olivier
背景法国官方卫生保健政策建议为所有婴儿和高危成人接种B型肝炎疫苗。参加我们的免费检测中心的性传播感染（FTC-STI）通常表达B肝炎疫苗犹豫。我们的目的是在这个暴露人群中探索有关HBV感染的知识程度，量化HBV疫苗拒绝，并确定这种拒绝的原因。方法.在2013年的3个月期间，格勒诺布尔FTC-STI的所有与会者都收到了一份匿名问卷，调查他们对B型肝炎的了解、对B型肝炎疫苗的看法、对当天免费接种B型肝炎疫苗的接受程度以及拒绝这一提议的原因（如适用）。结果735名参与者完成了问卷调查（占研究期间参与者的64.7%）（59.9%为男性;年龄27.9 +/- 9.2）。大多数受访者认为B型肝炎是法国存在的一种潜在的严重、潜在的终身疾病。关于B型肝炎疫苗，不到50%的人完全或大部分同意它是安全的;当被问及疫苗是否有危险时，44.2%的人回答“我不知道”，14.0%的人同意;当被问及疫苗是否“没有很好的表征”时，45.0%的人回答“我不知道”，26.5%的人同意。当被问及他们是否不信任B型肝炎疫苗或所有疫苗时，未接种疫苗的人分别有39.0%和28.9%表示同意。三分之二的人拒绝在同一天接种疫苗。当被问及是否害怕这种疫苗的不良反应时，只有18.7%的人不同意。结论对B型肝炎疫苗的负面看法在这一高危人群中普遍存在。因此，一个成功的沟通策略必须让这些高危人群相信疫苗的无害性。
Background. Official French health care policy recommends vaccinations against hepatitis B for all infants and at-risk adults. Attendees at our free testing center for sexually transmitted infections (FTC-STI) routinely express hepatitis B vaccine hesitancy. We aimed in this exposed population to explore the extent of knowledge concerning HBV infection, to quantify HBV vaccine refusal, and to identify the reasons for this refusal. Methods. During a 3-month period in 2013, all attendees at the Grenoble FTC-STI were given an anonymous questionnaire exploring their knowledge of hepatitis B, perception of the hepatitis B vaccine, acceptance of free same-day hepatitis B vaccination, and reasons for refusing this offer (where applicable). Results. The questionnaire was completed by 735 attendees (64.7% of those attending during the study period)(59.9% men; age 27.9 +/- 9.2). Most respondents identified hepatitis B as a potentially severe, potentially lifelong illness existing in France. Concerning the hepatitis B vaccine, less than 50% totally or mostly agreed that it is safe; when asked whether the vaccine is dangerous, 44.2% answered "I don't know" and 14.0% agreed; when asked whether the vaccine is "not well characterized," 45.0%, answered "I don't know" and 26.5% agreed. When asked whether they mistrust the hepatitis B vaccine or all vaccines in general, 39.0% and 28.9% of those unvaccinated agreed, respectively. Two thirds refused to get vaccinated on the same day. When asked whether they were afraid of the adverse effects of this vaccine, only 18.7% disagreed. Conclusion. Negative perceptions of the hepatitis B vaccine are widespread in this at-risk population. Consequently, a successful communication strategy must reassure this at-risk population of the vaccine's innocuous nature.